Article
Direct Comparisons of Efficacy and Safety Between Actinomycin-D and Methotrexate in Women With Low-Risk Gestational Trophoblastic Neoplasia: A Systematic Review and Meta-Analysis
2021-02-08
Abstract excerpt
<h4>Background: </h4> Actinomycin-D (Act-D) and Methotrexate (MTX) are both effective first-line agents for low-risk gestational trophoblastic neoplasia (LRGTN) with no consensus regarding which is more effective or less toxic. The primary objective of this meta-analysis is to compare Act-D with MTX in the treatment of LRGTN. <h4>Methods: </h4>: We systematically searched electronic databases, conferences abstract...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8fb829bd-5458-5b8c-91bc-433a43ff6260
- DOI
- 10.21203/rs.3.rs-151497/v1
